Close Menu
Home › Biomerieux Q3 Sales Up 7 Percent

Biomerieux Q3 Sales Up 7 Percent

Oct 20, 2016

NEW YORK (GenomeWeb) – Biomerieux reported today that its third quarter revenues rose 7 percent from Q3 2015, including a 46 percent jump in molecular biology sales.  

For the quarter ended Sept. 30, the company reported total revenues of €510.8 million ($557.3 million) from €478.3 million a year ago.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In PCR

  1. T2 Biosystems Q3 Revenues Drop 36 Percent; Firm Suffers Ransom Cyberattack

  2. ChromaCode Debuts Instrument-Agnostic Multiplex Panel for Multi-Drug Resistant Infection Screening

    Premium

  3. Bioneer Gets CE Mark for HCV Assay

  4. OraSure Strives for End-to-End Presence in Microbiome Market with Diversigen Buy

    Premium

  5. OpGen Posts 17 Percent Increase in Q3 Revenues

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.